Search research articles
Contact Us
Filters
Showing results (341-350 of 486) with videos related to
Page
of 49
Sort By:
Annals of Surgical Oncology
|
May 19, 2026
ASO Visual Abstract: Psoas Muscle Well-Differentiated Liposarcoma: A Distinct Anatomic Subset with Highly Favorable Outcomes
William W Tseng, Francesco Barretta, Marco Fiore, et al.
Annals of Surgical Oncology
|
June 12, 2026
Correction: ASO Visual Abstract: Well‑Differentiated Liposarcoma of the Psoas Muscle: A Distinct Anatomic Subset with Highly Favorable Outcomes
William W Tseng, Francesco Barretta, Marco Fiore, et al.
The Oncologist
|
December 7, 2018
Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study
Giovanni Fucà, Nadia Hindi, Isabelle Ray-Coquard, et al.
Annals of Surgical Oncology
|
May 5, 2026
Well-Differentiated Liposarcoma of the Psoas Muscle: A Distinct Anatomic Subset with Highly Favorable Outcomes
William W Tseng, Francesco Barretta, Marco Fiore, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2014
Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors
Emanuela Palmerini, Eric L Staals, Robert G Maki, et al.
Cancer
|
April 26, 2026
Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trial
Markus Albertsmeier, Valeria Milani, Lars H Lindner, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 2, 2021
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation
Valentina Zuco, Sandro Pasquali, Monica Tortoreto, et al.
Annals of Surgical Oncology
|
June 24, 2016
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database
Silvia Stacchiotti, Salvatore Provenzano, Gianpaolo Dagrada, et al.
Cancer
|
September 15, 2018
Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study
Silvia Stacchiotti, Carlo Morosi, Salvatore Lo Vullo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2016
Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome
Daniela Gasparotto, Sabrina Rossi, Maurizio Polano, et al.
Page
of 49
Search research articles
Search
Showing results (341-350 of 486) with videos related to
Sort By:
Page
of 49
Annals of Surgical Oncology
|
May 19, 2026
ASO Visual Abstract: Psoas Muscle Well-Differentiated Liposarcoma: A Distinct Anatomic Subset with Highly Favorable Outcomes
William W Tseng, Francesco Barretta, Marco Fiore, et al.
Annals of Surgical Oncology
|
June 12, 2026
Correction: ASO Visual Abstract: Well‑Differentiated Liposarcoma of the Psoas Muscle: A Distinct Anatomic Subset with Highly Favorable Outcomes
William W Tseng, Francesco Barretta, Marco Fiore, et al.
The Oncologist
|
December 7, 2018
Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study
Giovanni Fucà, Nadia Hindi, Isabelle Ray-Coquard, et al.
Annals of Surgical Oncology
|
May 5, 2026
Well-Differentiated Liposarcoma of the Psoas Muscle: A Distinct Anatomic Subset with Highly Favorable Outcomes
William W Tseng, Francesco Barretta, Marco Fiore, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2014
Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors
Emanuela Palmerini, Eric L Staals, Robert G Maki, et al.
Cancer
|
April 26, 2026
Neoadjuvant chemotherapy for soft-tissue sarcoma of the extremities: A post-hoc Sarculator-based risk analysis of the EORTC 62961-ESHO 95 randomized trial
Markus Albertsmeier, Valeria Milani, Lars H Lindner, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 2, 2021
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down-regulation
Valentina Zuco, Sandro Pasquali, Monica Tortoreto, et al.
Annals of Surgical Oncology
|
June 24, 2016
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database
Silvia Stacchiotti, Salvatore Provenzano, Gianpaolo Dagrada, et al.
Cancer
|
September 15, 2018
Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study
Silvia Stacchiotti, Carlo Morosi, Salvatore Lo Vullo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2016
Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome
Daniela Gasparotto, Sabrina Rossi, Maurizio Polano, et al.
Page
of 49